Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Research Finds Use of Volpara Solutions Quantitative Breast Imaging Tools Provides Actionable Intelligence for 2D and 3D Mammography Screening of Women with Dense Breasts
  • USA - English


News provided by

Volpara Solutions

Feb 26, 2014, 11:00 ET

Share this article

Share toX

Share this article

Share toX


Vienna, Austria (PRWEB) February 26, 2014 -- The ability of volumetric breast imaging data to provide actionable intelligence to guide screening of women with dense breasts with 2D and 3D mammography are among the key abstracts accepted for presentation at the European Congress of Radiology (ECR) meeting, March 6-10, 2014. According to Volpara Solutions, seven abstracts highlight the use of quantitative breast imaging software tools to provide Enterprise-wide breast care imaging and informatics, including volumetric density, patient-specific dose, and applied pressure.

The current study, using automated volumetric breast density estimations showed very good correlations between the 2D and 3D mammograms, as you might expect given the volumetric nature of the measurement," said Highnam.

Post this

The company will showcase the role of its suite of volumetric software tools in a number of large clinical trials, national breast cancer screening programs and hospitals across Europe. (ECR2014 - First level gallery, booth 619).

In the scientific exhibit titled, “Comparing personalized mean glandular dose estimates between x-ray systems over time in mammography” (C-0360), Dr. Ralph Highnam, CEO of Volpara Solutions and a co-author, demonstrates that patient-specific estimates of Mean Glandular Dose (MGD) could be used to help standardize dose monitoring for patients undergoing routine screening on different x-ray systems. The results indicate that the patient-specific estimates of MGD, which incorporate the individual glandularities of the women and use a standard dose algorithm, differ from, but correlate well with the reported doses from GE and Hologic systems. Compared to patient-specific estimates, the mammography systems tended to underestimate MGD.

In the study, “Volumetric breast density estimation on conventional mammography versus digital breast tomosynthesis” (C-0363) VolparaDensity was used to compare the assessment of volumetric breast density of conventional 2D mammograms to assessment of digital breast tomosynthesis (DBT) volumetric density. Results show that there was no significant difference between volumetric breast density, breast volume, and fibroglandular volume estimates from conventional mammograms or the DBT projections. The Volpara generated BI-RADS density scores matched for 19 out of 20 cases, indicating that there was very good agreement between density assessed from the DBT projections and the conventional mammograms. The results suggest that automated volumetric breast density methods are a promising alternative to visually assessed breast density assessments, and produce reliable and objective breast density estimations from both raw conventional mammograms and raw DBT projections.

“While only a few studies have investigated breast density results derived specifically from tomosynthesis, studies have shown significant differences in the density results from 2D and 3D mammography. The current study, using automated volumetric breast density estimations showed very good correlations between the 2D and 3D mammograms, as you might expect given the volumetric nature of the measurement. These results have additional implications for those wanting to monitor longitudinal changes in breast density or for studies looking at breast density as a breast cancer risk factor. Additionally, for sites wanting to implement the C-View module, to replace conventional mammography, automated volumetric methods like VolparaDensity can ensure consistency in breast density measures,” said Dr. Highnam.

Breast cancer screening programs strive to achieve an optimal balance between sensitivity and recall rates. The interpretation of screening mammograms is often challenging and highly variable, but the addition of multiple readers can improve cancer detection rates. While numerous variations in screening protocols have been studied, they have largely sought to apply one protocol across entire populations. In the study, “Effect of independent double and multiple reading of screening mammograms by breast density,” (C-0358) Professor Nico Karssemeijer et al of Nijmegen investigated the effect of increasing the number of independent readers on mammography sensitivity, for dense versus non-dense cases.

“In the United States, breast screening typically comprises annual mammography and single reading with CAD, whereas European guidelines recommend biennial mammography with independent double reading. Double interpretation of mammograms is a proven, effective strategy to improve cancer detection rates,” noted Professor Karssemeijer. “The benefit of additional readers on sensitivity was more pronounced in dense cases, suggesting that tailored screening based on breast density has the potential to improve breast cancer detection rates for this population of women. The allocation of multiple readers to mammograms that may be difficult to interpret offers a relatively simple and effective approach for improving screening performance on women with dense breasts, especially with automated density assessment systems and density-based workflow tools.”

In the study, “Mammographic Density Estimation by Volpara software: Comparison with Radiologists’ visual assessment and relationship with BI-RADS category” (C-1957) Professor L. Han Na of Seoul Korea, compares the automated volumetric breast density measurement with BI-RADS breast density assessed by radiologists’ visual estimates and analyze the clinico-radiologic factors that affect the disagreement. Results demonstrate that the automated volumetric breast density measurement shows good agreement with radiologists’ visual assessment of BI-RADS density category, with differences occurring more often when there were bilateral differences in density.

In addition, on Monday, March 10, 10:30 - 12:00 (Room F2), the Educational Session SS-1702, “Breast density and General Breast MRI,” will include three presentations that feature VolparaDensity:
• “Geographical variation in mammographic density distribution in the Netherlands” (B-0832); The preliminary results suggest that geographical variation in mammographic density distribution is present in the Netherlands, which would support structural assessment of breast density within the screening programme;
• “Volumetric breast density: can computer assessment really reduce human variability?” (B-0833); Volumetric breast density computer-based can remove inter-reader variability in categorization of dense breasts and following decisions about patient workup.
• “Visual and automated volumetric assessment of mammographic density (MD): do measurements depend on the digital mammography unit?” (B-0835); Variances between volumetric density measurements using Volpara™, obtained from GE Senographe and Hologic Selenia mammograms in the same women one year apart, were small and equally distributed in both directions, whereas human visual density scores were statistically significantly more likely to be higher in Senographe mammograms.

Cleared by the FDA, HealthCanada, the TGA and CE-marked, VolparaDensity is used by radiologists to objectively assess density from both digital mammography and tomosynthesis images and help evaluate who might benefit from additional screening. Highly correlated to breast MR assessments, VolparaDensity is a reliable tool which automatically generates an objective, automatic measurement of volumetric breast density and a FDA cleared BI-RADS breast density category. To date, more than 2 million women have had their volumetric breast density analyzed using VolparaDensity.

About Volpara Solutions
Founded to enable radiologists to give women the most accurate information possible regarding their breast health, Volpara Solutions is the wholly owned sales and marketing arm of Matakina Technology Limited of New Zealand. Matakina’s founders and Board of Directors includes John Hood, PhD, former Vice Chancellor of the University of Oxford, UK; Ralph Highnam, PhD, former CEO of Mirada Solutions, one of the University of Oxford’s most successful spin-outs of recent times and co-author of the seminal book Mammographic Image Analysis; and Professor Sir Michael Brady, a serial entrepreneur who recently retired from the University of Oxford where he was Professor of Information Technology for 25 years.

# # #

Chris K Joseph, Volpara Solutions, http://www.volparasolutions.com, +1 (510) 435-4031, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.